CROMA SAYPHA FILLER LIDOCAINE

saypha® FILLER
- Indication: For the correction of moderate to severe nasolabial folds. Used for cosmetic and medical reconstruction in the treatment of e.g. facial lipoatrophy, debilitating scars or morphological asymmetry.
- Injection area: mid to deep dermis -
Duration in the skin: 5 months (estimated)

saypha® FILLER Lidocaine
- Indication: to create volume to correct wrinkles and folds in order to treat the signs of ageing.
- Indication: the device is indicated to correct moderate to severe nasolabial folds and to increase lip volume.
- Injection area: mid to deep dermis and submucosa -
Duration in the skin: 9 months (estimated)

saypha® VOLUME
- Indication: for the correction of moderate to severe nasolabial folds and the medical treatment of reconstruction, e.g. facial lipoatrophy, debilitating scars or morphological asymmetry.
- Injection area: deep dermis or subcutaneous -
Duration in the skin: 9 months (estimated)

saypha® VOLUME Lidocaine
- Indication: create volume to correct wrinkles and folds to treat signs of aging.
- Indication: The device is indicated to correct moderate to severe nasolabial folds.
- Injection area: deep dermis or subcutaneous -
Duration in the skin: 9 months (estimated)

saypha® VOLUME PLUS Lidocaine
- Indication: for facial tissue augmentation to correct mid-face volume deficit, for facial volume restoration and contouring and for reconstruction purposes in the treatment of, for example, HIV-related facial lipoatrophy.
- Injection site: deep dermis, subcutaneous or superperiosteal -
Duration in the skin: 12 months (estimated)

saypha® RICH
- Indication: the device is a viscoelastic solution to replenish the loss of hyaluronic acid due to aging, to maintain hydration, improve skin tone and elasticity and act as a filler for small wrinkles such as crow's feet, smile lines or smoke lines around the mouth.
- Injection area: superficial dermal tissue

SAYPHA FILLER
- Ingredients
:Concentration: HA 2.3% (23 mg / mL), high molecular weight hyaluronic acid of non-animal origin.
Cross-linking agent: BDDE (concentration ≤ 2 ppm)
Additional ingredients: phosphate buffer, NaCl


SAYPHA FILLER LIDOCAINE-
Ingredients:
Concentration: 2.3% (23 mg / mL) high molecular weight hyaluronic acid of non-animal
originCross-linkingagent
: BDDE (concentration ≤ 2 ppm)
Additional ingredients: phosphate buffer, NaCl, 0.3% lidocaine hydrochloride


SAYPHA VOLUME-
Ingredients :
HA concentration: 2.3% (23 mg / mL) of high molecular weight hyaluronic acid of non-animal
originCrosslinkingagent
: BDDE (concentration ≤ 2 ppm)
Additional ingredients: phosphate buffer, NaCl


SAYPHA VOLUME LIDOCAINE-
Ingredients:
HA concentration: 2.3% (23 mg / mL) of high molecular weight hyaluronic acid of non-animal
originCrosslinkingagent
: BDDE (concentration ≤ 2 ppm)
Additional ingredients: phosphate buffer, NaCl, 0.3% lidocaine hydrochloride


SAYPHA VOLUME PLUS LIDOCAINEIngredients
:
HA concentration: 2.5% (25 mg / mL) high molecular weight hyaluronic acid of non-animal
originCrosslinkingagent
: BDDE (concentration ≤ 2 ppm)
Additional ingredients: phosphate buffer, NaCl, 0.3% lidocaine hydrochloride


SAYPHA RICHIngredients
:
HA concentration: 1.8% (18 mg / mL) high molecular weight hyaluronic acid of non-animal
originAdditionalingredients
: glycerol (20 mg / mL) glycerol is a polyhydric alcohol with the dual role of stabilizing hyaluronic acid and promoting skin
hydrationBufferingsystem
: phosphate citrate buffer

The products sold on www.fillermarket.com are parapharmaceutical products without restriction to the sale but must be used by a doctor.